EX-12.1 2 ex12_112312014htm.htm EXHIBIT 12.1 RATIO
Exhibit 12.1
 
Progenics Pharmaceuticals, Inc.
Ratio of Earnings (Loss) to Combined Fixed Charges and Preferred Stock Dividends
(in thousands)
 
 
  
Years Ended December 31,
  
 
  
2014
    
2013
    
2012
    
2011
    
2010
  
Determination of earnings (loss):
  
   
   
   
   
 
Income (loss) from operations
  
$
4,410
 
  
$
(42,934
)
  
$
(35,431
 )   
$
10,381
 
  
$
(69.820
)
Add:
                                        
Fixed charges
    
373
      
710
      
410
      
695
      
709
  
 
                                        
Earnings (loss), as adjusted
  
$
4,783
 
  
$
(42,224
)
  
$
(35,021
 )   
$
11,076
 
  
$
(69,111
)
 
                                        
Fixed charges:
                                        
 
                                        
Estimate of interest within rental expense
    
373
      
710
      
410
      
695
      
709
  
 
                                        
Fixed charges
  
$
373
    
$
710
    
$
410
    
$
695
    
$
709
  
 
                                        
Preferred stock dividends
  
$
-
    
$
-
    
$
-
    
$
-
    
$
-
  
 
                                        
Ratio of earnings (loss) to fixed charges and preferred stock dividends
    
13
      
*
      
*
      
16
      
*
  
Coverage deficiency amount for total fixed charges and preferred stock dividends (1)
  
$
-
    
$
42,934
    
$
35,431
    
$
-
    
$
69,820
  

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(1)
For the years ended 2010, 2012 and 2013, the Company's coverage ratio is less than one-to-one and it must generate additional earnings of these specified amounts to achieve a coverage ratio of 1:1.